<code id='E3119705A3'></code><style id='E3119705A3'></style>
    • <acronym id='E3119705A3'></acronym>
      <center id='E3119705A3'><center id='E3119705A3'><tfoot id='E3119705A3'></tfoot></center><abbr id='E3119705A3'><dir id='E3119705A3'><tfoot id='E3119705A3'></tfoot><noframes id='E3119705A3'>

    • <optgroup id='E3119705A3'><strike id='E3119705A3'><sup id='E3119705A3'></sup></strike><code id='E3119705A3'></code></optgroup>
        1. <b id='E3119705A3'><label id='E3119705A3'><select id='E3119705A3'><dt id='E3119705A3'><span id='E3119705A3'></span></dt></select></label></b><u id='E3119705A3'></u>
          <i id='E3119705A3'><strike id='E3119705A3'><tt id='E3119705A3'><pre id='E3119705A3'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:938
          Scientific watchdogs Sholto David (right) and Elisabeth Bik join STAT's Jonathen Wosen at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

          SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.” The possibility that AI-generated, fraudulent data could be making its way into more established journals is a constant fear.

          But institutions and academic journals aren’t doing enough about it, she said at the STAT breakthrough summit in San Francisco.  

          advertisement

          While artificial intelligence can be a powerful research tool when used legitimately, it’s also “absolutely frightening to me what AI can generate,” Bik said. “I’m worried this has already infiltrated scientific literature. It’s hard to tell [AI-generated images] apart from real photos. They look so real. I feel publishers are not putting [in] enough effort to deal with it — how do we find the fake photos?”

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          First U.S. drug developed to treat liver disease MASH is approved
          First U.S. drug developed to treat liver disease MASH is approved

          AdobeTheFoodandDrugAdministrationonThursdayapprovedthefirstmedicinedevelopedspecificallytotreatthese

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Medicare coverage of Wegovy, once blocked, now looks possible

          SteffenTrumpf/picturealliance/GettyImagesWASHINGTON— NovoNordisk’snewlywonpermissiontomarkettheheart